pulmonx LUNG 深 滬
等待開盤 12-12 09:30:00 美东时间
2.51
+0.050
+2.03%
華盛通- 最 高2.53
- 今 開2.47
- 成交量 95.39万股
- 最 低 2.37
- 昨 收 2.46
- 總市值 1.02亿
- 52周最高 9.37
- 市盈率 靜 --
- 換手率 2.34%
- 52周最低 1.31
- 委 比 -89.93%
- 總股本 4074.66万
- 歷史最高 69.478
- 量 比 0.70
- 振 幅 6.50%
- 歷史最低 1.31
- 每 手 1
- 風險率 2.29%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Pulmonx Corporation granted equity awards totaling 1,625,000 shares to two new hires in Q4 2025, including Chief Financial Officer and Chief Operating Officer Derrick Sung. 1,225,000 RSUs were awarded, with 1,200,000 allocated to Sung. RSUs vest over four years, with 25% vesting at one year and the rest in quarterly installments. Additionally, Sung received up to 400,000 PSUs, subject to time-based vesting over three years and a performance condi...
12-03 21:05
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
D. Boral Capital Maintains Buy on Pulmonx, Maintains $14 Price Target
D. Boral Capital analyst Jason Kolbert maintains Pulmonx (NASDAQ:LUNG) with a Buy and maintains $14 price target.
11-13 21:59
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
11-12 19:11
Pulmonx's Earnings: A Preview
Pulmonx (NASDAQ:LUNG) is preparing to release its quarterly earnings on Wednesd...
11-12 04:03
MIRXES-B（02629.HK）10月30日收盘跌1.6%，主力资金净流出544.95万港元
证券之星消息，截至2025年10月30日收盘，MIRXES-B(02629.HK)报收于64.5港元，下跌1.6%，成交量112.3万股，成交额7363.25万港元。
10-30 18:59
Earnings Scheduled For October 29, 2025
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
Pulmonx reports Q3 Preliminary results
Pulmonx press release (NASDAQ:LUNG): Q3 revenue expected to be approximately $21.5 million More on Pulmonx Pulmonx slumps as Piper Sandler downgrades despite Q2 beat Seeking Alpha’s Quant Rating on ...
10-29 17:31
美股大行评级 | 上调！苹果、亚马逊、Amkor Tech、Cadence、Confluent、卡特、通用动力等获多家上调目标价
今日重点评级关注：HC Wainwright & Co.：维持PepGen"买入"评级，目标价从12美元升至18美元；Piper Sandler：维持Prothena Corp"超配"评级，目标价从15美元升至36美元
10-29 09:25
Pulmonx Preliminary, Unaudited Q3 2025 Revenue Expected To Be ~$21.5M
Preliminary, Unaudited Third Quarter 2025 RevenueTotal worldwide revenue for the third quarter of 2025 is anticipated to be approximately $21.5 million.The Company plans to provide further details on its third quarter
10-28 04:22
